Related by context. All words. (Click for frequent words.) 73 rotavirus infection 72 rotavirus gastroenteritis 71 vaccine serotypes 71 CMV infection 69 external genital lesions 69 pneumococcal infection 69 genital herpes infections 68 recurrent VTE 68 nonvaccine serotypes 68 HPV-#/# 68 pneumococcal infections 68 CMV disease 67 candidemia 67 spontaneous preterm delivery 67 PCV7 vaccine 67 FluCAM arm 67 rebleeding 66 serogroups 66 pneumococcal serotypes 66 seropositivity 66 RSV infections 66 recurrent venous thromboembolism 66 serogroup C 66 intracranial hemorrhage ICH 65 HBeAg seroconversion 65 seroprotection 65 pH#N# 65 serogroup 65 hemorrhagic complications 65 hematologic toxicity 65 ALT flares 65 thrombotic complications 65 virological response 65 Virologic failure 65 P. falciparum malaria 65 anemia hemoglobin 65 invasive candidiasis 65 COPD exacerbations 65 NNRTI resistance 65 susceptible isolates 65 recurrent genital herpes 65 venous blood clots 65 pneumococci 64 CIN3 64 VZV 64 antibody titers 64 bacterium Neisseria meningitidis 64 latent tuberculosis infection 64 quadrivalent vaccine 64 Staphylococcus aureus infections 64 invasive meningococcal disease 64 rotavirus diarrhea 64 HBeAg negative 64 invasive aspergillosis 64 vaccinees 64 fluoroquinolone resistance 64 trimethoprim sulfamethoxazole 64 thromboembolic complications 64 invasive pneumococcal disease 64 relapsed MM 64 transaminase elevations 64 hepatitis C genotype 64 varicella zoster virus VZV 64 tuberculin skin testing 64 CP CPPS 63 COPD exacerbation 63 Febrile neutropenia 63 pneumococcal pneumonia 63 S. aureus infections 63 b Hib 63 neurologic sequelae 63 N. gonorrhoeae 63 corticosteroid therapy 63 complete cytogenetic response 63 paralytic poliomyelitis 63 advanced adenoma 63 Hib disease 63 virological failure 63 S. aureus infection 63 ALT elevation 63 LTBI 63 Postoperative complications 63 TEAEs 63 low expressors 63 nephrotoxicity 63 upper gastrointestinal bleeding 63 serotype #A 63 salmeterol HFA MDI 63 reactogenicity 63 gastrointestinal toxicity 63 fetal malformations 63 parasitaemia 63 thrombocytopenic 63 BRSV 63 venous thromboembolic events 63 morphometric vertebral fractures 63 Plasmodium infection 63 endophthalmitis 63 severe exacerbations 63 malarial anemia 63 oral poliovirus 62 serogroup B 62 herpes zoster virus 62 HbF 62 coinfection 62 palivizumab 62 CIN2 + 62 SRBD 62 anal cancers 62 chlamydial infection 62 antibody titer 62 hepatitis B infection 62 G6PD deficiency 62 thromboembolic events 62 BCG vaccinated 62 HPA axis suppression 62 atrophic gastritis 62 herpes zoster 62 corticosteroid dose 62 evaluable subjects 62 valent pneumococcal conjugate vaccine 62 posaconazole 62 reinfarction 62 definite stent thrombosis 62 S. pneumoniae 62 neurologic complications 62 lymphopenia 62 renal scarring 62 systemic corticosteroids 62 CIMZIA ™ 62 contrast induced nephropathy 62 genital ulcers 62 nonvaccine 62 Non inferiority 62 nonmelanoma skin cancers 62 chronic GVHD 62 octreotide LAR 62 neutropenia dehydration dyspnea 62 HPV subtypes 62 Twinrix 62 immunocompetent patients 62 histologic subtype 62 Helicobacter pylori H. pylori 62 Neisseria meningitidis 62 HBV infections 62 HCV genotypes 62 Toxicities 62 imipenem 62 malignant neoplasm 62 neutropenic fever 62 neutropenic patients 62 combination antiretroviral therapy 62 SIV infection 62 severe neutropenia 62 Haemophilus influenzae 62 seroconversion 62 chronic HBV infection 62 dysplastic lesions 62 genital ulcer disease 62 Salmonella typhi 62 colorectal adenoma 62 serum urate levels 62 virologic response 61 arterial thromboembolic events 61 viremia 61 perioperative mortality 61 incidence ≥ 61 polysaccharide vaccine 61 S aureus 61 gastric adenocarcinoma 61 antimicrobial prophylaxis 61 neutrophil counts 61 Plasmodium falciparum malaria 61 renal toxicity 61 cervical vulvar 61 KRAS mutations occur 61 serum aminotransferase levels 61 ertapenem 61 recurrent wheezing 61 grade cervical intraepithelial 61 varicella zoster virus 61 precancerous cervical lesions 61 immunocompetent 61 timepoints 61 hypophosphatemia 61 Candida infection 61 HBV DNA levels 61 neutropaenia 61 pyrazinamide 61 cervical lesions 61 methicillin susceptible Staphylococcus aureus 61 oral FTY# 61 amoxicillin clavulanate 61 ganciclovir 61 postoperative morbidity 61 NNRTI resistant virus 61 nucleoside naive patients 61 CDI recurrence 61 intravenous bisphosphonates 61 cervical vaginal 61 HIV HCV coinfected 61 chlamydial infections 61 oncogenic HPV types 61 CR nPR 61 genotypic resistance 61 lopinavir r arm 61 malarial infection 61 transgene expression 61 poliovirus vaccine 61 vaginal cancers 61 microbiological eradication 61 Candida species 61 uncomplicated malaria 61 metastatic neuroendocrine tumors 61 glycated hemoglobin levels 61 del 5q MDS 61 vWD 61 parasitemia 61 Neisseria gonorrhoeae 61 H. influenzae 61 T1DM 61 cidofovir 61 CRBSI 61 precursor lesions 61 rotaviruses 61 Candida infections 61 postexposure 61 nonmelanoma skin cancer 60 inhibitory antibodies 60 pyrexia mucositis sepsis febrile 60 severe asthma exacerbations 60 trivalent inactivated influenza 60 curative resection 60 ischemic complications 60 virologic failure 60 HBV infection 60 chronic rhinosinusitis 60 bacteria Streptococcus pneumoniae 60 intraoperative complications 60 chronic periodontitis 60 nonvertebral fracture 60 ximelagatran 60 NAbs 60 causative pathogen 60 K#N 60 NRTI resistance 60 RSV infection 60 postexposure prophylaxis 60 hypokalemia 60 severe oral mucositis 60 log# reduction 60 recurrent UTI 60 S. aureus isolates 60 reinterventions 60 Acute myeloid leukemia 60 hepatorenal syndrome 60 EXJADE 60 TMP SMX 60 Infusion Reactions Severe 60 cervical intraepithelial neoplasia 60 C. trachomatis 60 perioperative complications 60 APTIVUS r 60 cerebral vasospasm 60 Plasmodium vivax 60 myalgia arthralgia 60 Thrombocytopenia 60 circulating rotavirus 60 leukopenia 60 invasive pneumococcal diseases 60 hemagglutination inhibition 60 seroprevalence 60 EBV infection 60 vesicoureteral reflux 60 neutralizing antibody 60 ALT elevations 60 paroxysmal AF 60 CMV infections 60 invasive fungal infections 60 chronic HBV 60 non hematological toxicities 60 N. meningitidis 60 protease inhibitors PIs 60 IV bisphosphonates 60 Bacillus Calmette Guerin BCG 60 postoperative complication 60 hepatitis B immunoglobulin 60 RSV hospitalizations 60 enterocolitis 60 recurrent miscarriage 60 hyperbilirubinemia 60 transfusion syndrome 60 HBeAg 60 arterial calcification 60 transaminase levels 60 deferiprone 60 neurological sequelae 60 elevated triglyceride levels 60 fluconazole resistant 60 HBsAg 60 antiviral efficacy 60 serum HCV RNA 60 linezolid resistant 60 cytomegalovirus infection 60 cranial irradiation 60 malignant neoplasms 60 dengue viruses 60 acute GvHD 60 symptomatic VTE 60 mcg BID 60 mcg mL 60 thrombotic events 60 mycophenolate mofetil 60 ADPKD 60 symptomatic intracranial hemorrhage 60 Pneumocystis carinii pneumonia 60 enterovirus infection 60 meningococcus 60 androgen deprivation 60 virologic breakthrough 60 neoplasias 60 leucopenia 60 laboratory abnormalities 60 virus HBV 60 dengue hemorrhagic fever DHF 60 PPSV# 60 chronic HCV infection 60 Anaphylactic reactions 60 tipranavir ritonavir 60 RSV bronchiolitis 60 acute respiratory tract infections 60 biologic DMARD 60 grade cervical dysplasia 60 tacrolimus ointment 60 HPV# 60 immunopathology 60 MIC# [001] 60 mg kg dose 60 hepatotoxicity 60 delayed CINV 60 BCG vaccination 60 viral titers 60 pulmonary dysfunction 60 HIV uninfected 60 GABHS 60 systemic toxicity 60 Hepatitis C virus HCV 60 serious pneumococcal infections 60 sexually transmitted HPV 60 pertussis tetanus 60 CIMZIA TM 60 H pylori 59 corneal infection 59 varicella infection 59 leiomyomas 59 polyp recurrence 59 steroid dexamethasone 59 MRSA colonization 59 HBeAg positive 59 carotid stenosis 59 antibody responses 59 TNF antagonist 59 mediastinitis 59 Escherichia coli Klebsiella pneumoniae 59 hyperoxaluria 59 hypoglycemic episodes 59 ROTARIX 59 indinavir 59 potent antiretroviral therapy 59 Immune responses 59 herpes zoster shingles 59 chlamydial 59 β blockers 59 ruptured aneurysms 59 chemotherapy induced neutropenia 59 generalized edema 59 Hematologic toxicity 59 angiographic restenosis 59 HAV infection 59 Genital herpes 59 Hib meningitis 59 thromboembolism 59 pyelonephritis 59 polysaccharide vaccines 59 HER2 overexpression 59 severe hyperbilirubinemia 59 HIV coinfected 59 Listeria infections 59 Flu Cy 59 acute GVHD 59 advanced adenomas 59 rotavirus strains 59 febrile neutropenia 59 leukocyte count 59 invasive ductal 59 WNV infections 59 skeletal metastases 59 P vivax 59 ano genital warts 59 zoster 59 PASI scores 59 HBeAg negative patients 59 protease inhibitor PI 59 diarrheal deaths 59 bacteremia 59 NNT = 59 MMRV vaccine 59 atopic disease 59 orchitis 59 ocular toxicity 59 clodronate 59 neonatal morbidity 59 Routine immunization 59 GRNOPC1 cells 59 Novartis MenB vaccine 59 antibody titres 59 alemtuzumab treated 59 undetectable viral loads 59 recurrent glioblastoma multiforme 59 colorectal neoplasia 59 herpesviruses 59 ipsilateral stroke 59 Myelosuppression 59 serum creatinine levels 59 postoperative AF 59 tigecycline 59 IFN beta 59 HCV infections 59 basal cell carcinoma BCC 59 % CI #.#-#.# [007] 59 placental malaria 59 hepatic fibrosis 59 renal flares 59 Streptococcus pneumoniae 59 postoperative infections 59 caspofungin 59 sustained virologic response 59 aged ≥ 59 invasive pneumococcal infections 59 IGFD 59 leukemic transformation 59 BCR ABL mutations 59 invasive fungal infection 59 Hypotension 59 chronic hepatitis B. 59 myopathy rhabdomyolysis 59 bacterial colonization 59 humoral responses 59 C difficile infection 59 hypoperfusion 59 chronic hepatitis cirrhosis 59 Streptococcus pyogenes 59 bacteremic pneumonia 59 nonvertebral fractures 59 CCR5 tropic HIV 59 cutaneous squamous cell carcinoma 59 endometrial hyperplasia 59 receiving VICTRELIS 59 tapentadol ER 59 CsA 59 virologic failures 59 hemorrhagic cystitis 59 invasive Hib 59 LV dysfunction 59 H. pylori eradication 59 proctitis 59 graft dysfunction 59 riociguat 59 MGUS 59 nucleoside analogues 59 Aspergillus infections 59 serotypes 59 Epstein Barr virus EBV 59 SSc 59 biochemical relapse 59 MRSA isolates 59 neurodevelopmental impairment 59 diphtheria pertussis 59 CANCIDAS 59 HeFH 59 Neutropenia 59 enteroviral infection 59 severe hypersensitivity reactions 59 PSA nadir 59 recurrent infections 59 ribavirin therapy 59 HSCT 59 virologic responses 59 recurrent DVT 59 bronchopulmonary dysplasia 59 sotalol 59 vaginal lesions 59 serum HBV DNA 59 CCyR 59 perioperative morbidity 59 CTAP# Capsules 59 hypoglycaemic episodes 59 HBeAg positive patients 59 serum ALT 58 enterococcal 58 reinfection 58 Human cl 58 venous thromboembolic disease 58 HBV genotype 58 Chlamydia infection 58 osteosarcomas 58 esophagitis 58 abacavir lamivudine 58 antibiotic prophylaxis 58 anterior uveitis 58 HER2 expression 58 undetectable HBV DNA 58 Chlamydia trachomatis 58 TT genotype 58 GISTs 58 bacteraemia 58 CIN3 + 58 immunosuppression 58 haematological toxicity 58 Angioedema 58 Relapsing remitting MS 58 intensive statin therapy 58 C1 INH deficiency 58 locoregional recurrence 58 HGPIN 58 chorioamnionitis 58 EDSS scores 58 Vibrio infections 58 AZT zidovudine Retrovir 58 atherothrombotic events 58 immunological responses 58 enterotoxigenic E. coli 58 bacterial pneumonias 58 bacterium Mycobacterium tuberculosis 58 serologic testing 58 adrenal insufficiency 58 spontaneous preterm birth 58 symptomatic aortic stenosis 58 coagulopathy 58 micafungin 58 cytogenetic responses 58 neurological manifestations 58 Intussusception 58 Streptococcus pneumonia 58 symptomatic pulmonary embolism 58 asthma exacerbation 58 SGPT 58 rFVIIa 58 chloride secretion 58 endometrial carcinoma 58 P aeruginosa 58 hematological toxicities 58 hepatocellular cancer 58 paralytic polio 58 variceal bleeding 58 Herpes simplex virus 58 μg dL 58 VUR 58 macrovascular events 58 sustained virological response 58 Hepatitis B Virus 58 parkinsonian symptoms 58 post surgical adhesions 58 ovarian hyperstimulation syndrome OHSS 58 % CI #.#-#.# [003] 58 varicella vaccine 58 dapsone 58 alanine aminotransferase ALT 58 coronary stenoses 58 alanine aminotransferase 58 immunosuppressed patients 58 lymphocyte counts 58 tumor recurrence 58 CIN2 58 heavily pretreated 58 S. aureus colonization 58 gonococcal infections 58 Ribavirin causes 58 Chlamydia trachomatis infection 58 IgA deficiency 58 diphtheria pertussis whooping cough 58 myocardial ischaemia 58 liver decompensation 58 microg 58 K ras mutations 58 immunodeficient 58 nadroparin 58 HNSCC 58 adrenal suppression 58 Hydroxyurea 58 acute rheumatic fever 58 PCV7 58 gastrointestinal perforation 58 Staphylococcus aureus MRSA 58 prolonged QT interval 58 PRADAXA #mg 58 Heavy menstrual bleeding 58 REYATAZ r arm 58 H. pylori infection 58 varices 58 dopaminergic therapy 58 Human Papilloma Virus 58 seronegative 58 autoimmune reactions 58 transfusion transmitted 58 anal HPV 58 varicella vaccines 58 homocysteine concentrations 58 probiotic supplementation 58 CHD CVD 58 adjunctive placebo 58 intermittent hypoxia 58 hypoxemia 58 testicular tumors 58 tumor regressions 58 myocardial reperfusion 58 Clostridium difficile infections 58 thromboses 58 ethambutol 58 HBV DNA 58 MCyR 58 preventing precancerous lesions 58 salmeterol fluticasone 58 oxycodone CR 58 Enterobacter cloacae 58 androgen suppression 58 dose cohort 58 dyslipidaemia 58 mcg albinterferon alfa 2b 58 VaD 58 ARCOXIA 58 Hepatitis B virus 58 Cryptococcus neoformans 58 Aortic stenosis 58 adenoma recurrence 58 sputum cultures 58 Menveo 58 variceal 58 respiratory viral infections 58 inflammatory acne 58 adverse reactions incidence 58 inactivated poliovirus vaccine 58 viraemia 58 quadrivalent 58 Acute Radiation Syndrome ARS 58 HPV Human Papillomavirus 58 clinically asymptomatic 58 maternal morbidity 58 pericardial effusions 58 recurrent metastatic 58 venous thromboembolic 58 PREZISTA r 58 4CMenB 58 Acute Bacterial Sinusitis ABS 58 Renal impairment 58 hyperalgesia 58 serum phosphate 58 idraparinux 58 P. vivax malaria 58 elevated ALT 58 mycophenolate mofetil MMF 58 superinfection 58 piperacillin tazobactam 58 virologic 58 infective endocarditis 58 co trimoxazole 58 immunodeficiency 58 valacyclovir 58 pneumococcal vaccination 58 pharmacokinetic interactions 58 suppressive therapy 58 Recurrences 58 proliferative diabetic retinopathy 58 reintubation 58 neutropenic 58 HIV seronegative 58 MCV4 58 dexrazoxane 58 choline intake 58 hemoptysis 58 Adefovir 58 poor metabolizers 58 PAOD 58 neurologic outcomes 58 WNV infection 58 thromboprophylaxis 58 Hb A1C 58 amphotericin B 58 foveal thickness 58 prostate cancer CaP 58 calculated creatinine clearance 58 dysmenorrhoea 58 NNRTIs 58 basal cell nevus syndrome 58 herpes infection 58 p = NS 58 MenB strains 58 hepatitis B virus HBV 58 HbA 1c levels 58 SLNB 58 overt nephropathy 57 Pulmonary embolism 57 ventricular tachyarrhythmia 57 plasma viremia 57 Liver cirrhosis 57 HBV vaccine 57 bone marrow suppression 57 elevated IOP 57 VT VF 57 acellular pertussis DTaP 57 metastatic GIST 57 PHPT 57 E. faecalis 57 inhospital 57 adverse reactions occurring 57 solithromycin 57 advanced neoplasia 57 bacterial vaginosis BV 57 acromegalic patients 57 nucleotide analog 57 serum antibody 57 post thrombotic syndrome 57 Ishak fibrosis score 57 oxacillin 57 hepatic cirrhosis 57 MenB 57 suboptimal adherence 57 systemic absorption 57 colorectal carcinomas 57 rotavirus infections 57 atheroma volume 57 empiric treatment 57 Strep bacteria 57 events SAEs 57 platelet reactivity 57 recurrent glioma 57 gonococcal infection 57 tuberculous 57 Respiratory Syncytial Virus RSV 57 angioneurotic edema 57 intraoperative bleeding 57 β blocker 57 inhibitory concentration 57 pheochromocytoma 57 serum calcium 57 febrile seizure 57 Asymptomatic 57 dentinal hypersensitivity 57 gastrointestinal toxicities 57 bacteria Neisseria meningitidis 57 chronic granulomatous disease 57 mucosal inflammation 57 fatal hemorrhagic 57 KRAS status 57 S. Typhimurium 57 antiretroviral naive 57 locoregional disease 57 transgenic rats 57 HCV genotype 57 pneumococcus 57 NHANES III 57 initiating antiretroviral therapy 57 darunavir r 57 cryptococcal meningitis 57 #mg BID [001] 57 anemia neutropenia 57 Trypanosoma brucei 57 hematologic adverse 57 expressors 57 cervical carcinoma 57 abnormal Pap smears 57 anagrelide 57 nevirapine Viramune 57 MenACWY 57 Peripheral neuropathy 57 simplex virus 57 leukemia ALL 57 plasma HCV RNA 57 corticosterone levels 57 cancerous cervical lesions 57 pCR 57 dysglycemia 57 empiric therapy 57 serotype 57 liver histology 57 vulvar cancers 57 bezafibrate 57 macrolide antibiotic 57 atrial tachyarrhythmias 57 epiglottitis 57 gout flares 57 Natalizumab 57 ovarian carcinoma 57 receiving XGEVA 57 pneumococcal meningitis 57 efavirenz Sustiva 57 invasive pneumococcal 57 Abdominal aortic aneurysms 57 Erythropoietic therapies may 57 de novo AML 57 HbA1C levels 57 trastuzumab Herceptin ® 57 IOP lowering 57 Human Papillomavirus 57 fragility fracture 57 acetabular dysplasia 57 Influenza vaccination 57 antiretroviral prophylaxis 57 immuno suppression 57 cEVR 57 febrile illness 57 oral allopurinol 57 polioviruses 57 μg ml 57 mutated KRAS gene 57 aspartate aminotransferase 57 mucocutaneous reactions 57 Telbivudine 57 hepatic toxicity 57 Hepatotoxicity 57 tetravalent vaccine 57 anastomotic leak 57 pegIFN 57 plasma pharmacokinetics 57 CD# upregulation 57 valent vaccine 57 Index CDAI 57 seroconverted 57 Pneumocystis 57 pneumococcus bacteria 57 osteoporotic fractures 57 voriconazole 57 FOLFIRI alone 57 tardive dyskinesia TD 57 EDSS score 57 peginterferon alfa 2a 57 certolizumab 57 Salmonella spp 57 serum calcium levels 57 Adhibit 57 7 valent pneumococcal 57 unstable angina pectoris 57 hematological toxicity 57 pneumococcal illnesses 57 staphylococcal infections 57 Exacerbations 57 IgE mediated 57 hypomagnesemia 57 femoral neck fracture 57 mesotheliomas 57 seroprotective 57 adnexal mass 57 falciparum malaria 57 fluvastatin 57 recurrent myocardial infarction 57 otitis media ear 57 p = #.# [003] 57 neuroblastoma tumors 57 pharyngeal cancer 57 asthma exacerbations 57 lopinavir 57 MenACWY CRM 57 Bacille Calmette Guerin BCG 57 K#R [002] 57 bronchopulmonary dysplasia BPD 57 Human papilloma virus 57 Human Papillomavirus HPV 57 anal incontinence 57 neurodevelopmental outcome 57 Critical limb ischemia 57 thrombocytopenia neutropenia 57 ALI ARDS 57 pimecrolimus cream 57 inactivated vaccines 57 intestinal metaplasia 57 Neisseria meningitidis serogroups 57 parasite Plasmodium falciparum 57 postoperative mortality 57 conjunctival hyperemia 57 anogenital warts 57 dengue hemorrhagic fever 57 colorectal adenomas 57 chancroid 57 Hib vaccination 57 pathologic fractures 57 iPrEx study 57 postpartum hemorrhage 57 revascularizations 57 bacterium Streptococcus 57 recurrent atrial fibrillation 57 cotrimoxazole 57 nosocomial infection 57 lymphocytosis 57 dosage regimens 57 adenomatous polyps 57 selenium supplementation 57 postoperative infection 57 systemic corticosteroid 57 cTnT 57 amikacin 57 CRBSIs 57 decompensated liver disease 57 radiographic progression 57 HPV genotypes 57 histological subtype 57 Nilotinib 57 Pneumococcal vaccine 57 DVT PE 57 methicillin resistant MRSA 57 4mg/kg 57 Pneumococcal pneumonia 57 T#I mutant 57 CVD mortality 57 Measles mumps 57 proximal DVT 57 HPV types 57 cisplatin chemotherapy 57 PSADT 57 vulvar vaginal 57 immunized mice 57 squamous cell cancers 57 baseline HbA1c 57 T. vaginalis 57 coinfected 57 human papillomaviruses HPV 57 precancerous adenomas 57 HAART regimens 57 diphtheria pertussis tetanus 57 INFERGEN 57 BARACLUDE ® 57 pyridostigmine 57 parasite Trypanosoma cruzi 57 detectable HCV RNA 57 habitual snoring 57 seropositive patients 57 efalizumab 57 febrile seizures 57 zoster vaccine 57 retransplantation 57 renal cell carcinomas 57 Plasmodium ovale 57 hypertrophic scars 57 PegIFN RBV 57 S. pyogenes 57 Human papillomavirus 57 antigenicity 57 imatinib therapy 57 OAB symptoms 57 urolithiasis 57 fluticasone salmeterol 57 CYPHER Stent 57 recurrent ischemic stroke 57 CERVARIX 57 atherothrombotic disease 57 BARACLUDE resistance 57 lichen planus 57 wild poliovirus 57 postvaccination 57 eczema vaccinatum 57 intra articular injection 57 anaphylactoid reactions 57 Opportunistic infections 57 CrCl 57 haemorrhagic 57 induces antibodies 57 pericardial effusion 57 ovulatory cycles 57 serum testosterone 57 antiandrogens 57 Enterococcus faecium 56 acute aortic dissection 56 proliferative retinopathy 56 surgical debulking 56 HIB vaccine 56 ritonavir boosted lopinavir 56 generalized seizures 56 related hematological toxicity 56 abnormal Pap tests 56 intravascular hemolysis 56 ReA 56 conjugate vaccine 56 REYATAZ ritonavir 56 ceftriaxone 56 postoperative delirium 56 microbiologically evaluable 56 QTc prolongation 56 subtrochanteric 56 colorectal carcinoma 56 Virologic 56 Mycoplasma pneumoniae 56 pulmonary TB 56 malaria endemic regions 56 BSIs 56 colorectal liver metastases 56 superficial bladder cancer 56 UVB exposure 56 anti HBs 56 cardiac toxicity 56 Hip fracture